Slower clozapine titration than the official Japanese protocol led to fewer inflammatory adverse effects: A retrospective chart review of seven hospitals-Reference-Cited by-同舟云学术

Slower clozapine titration than the official Japanese protocol led to fewer inflammatory adverse effects: A retrospective chart review of seven hospitals

Published:2023-06 Issue: Volume: Page:
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Kikuchi Yuki,Komatsu Hiroshi,Otsuka Yuji,Ito Fumiaki,Kanahara Nobuhisa,Tanifuji Hiroaki,Tomita Hiroaki

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference36 articles.

1. Clozapine underutilization in the treatment of schizophrenia: how can clozapine prescription rates be improved?;Bogers;J. Clin. Psychopharmacol.,2016

2. The history of clozapine and its emergence in the US market: a review and analysis;Crilly;Hist. Psychiatry,2007

3. Clozapine-associated myocarditis in the World Health Organization’s pharmacovigilance database: focus on reports from various countries;De Las Cuevas;Rev. Psiquiatr. Salud Ment.,2021

4. Core clinical manifestations of clozapine-related DRESS syndrome: A network analysis;de Filippis;Schizophr. Res.,2022

5. Pharmacovigilance approaches to study rare and very rare side-effects: the example of clozapine-related DiHS/DRESS syndrome;de Filippis;Expert Opin. Drug Saf.,2022

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of titration speed, gender, obesity and concomitant medications on the risk and onset time of clozapine-associated fever among Japanese patients with schizophrenia: retrospective review of charts from 21 hospitals;The British Journal of Psychiatry;2024-08-06

2. Investigating in VigiBase over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: focus on high lethality and the association with aspiration pneumonia;Expert Opinion on Drug Metabolism & Toxicology;2024-07-02

3. When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis;CNS Drugs;2024-07-01

4. A Pharmacovigilance Study on Clozapine in the Food and Drug Administration Adverse Event Reporting System: A Regional Comparative Analysis;Clinical Psychopharmacology and Neuroscience;2024-06-07

5. Effect of concomitant use of valproic acid during clozapine initiation on clozapine-induced inflammation among Japanese patients with schizophrenia;Psychiatry Research;2024-04